Infection prevention enterprise risk demands direct board engagement and informed oversight to reduce financial, operational, and reputational harm.
Healthcare-associated infections (HAIs) continue to represent a major challenge for health systems worldwide, significantly impacting patient outcomes and contributing to increased healthcare costs.